GE Healthcare, a division of GE Corp., is looking to enter the real-time label-free protein interaction analysis market by acquiring Biacore AB for SEK330 per share, an offer that values the company at SEK3.2 billion (US$435.9 million) or about SEK2.9 billion net of Biacore's cash reserves. (BioWorld International) Read More
